Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Castagna

Showing results (111-120 of 146) with videos related to

Pageof 15
Sort By:
HIV Medicine|August 19, 2011
The rate of accumulation of nonnucleoside reverse transcriptase inhibitor (NNRTI) resistance in patients kept on a virologically failing regimen containing an NNRTI*A Cozzi-Lepri, Paredes, A N Phillips, et al.
Journal of Neurology|January 1, 1997
A comparison of brain biopsy and CSF-PCR in the diagnosis of CNS lesions in AIDS patientsA d'Arminio Monforte, P Cinque, L Vago, et al.
HIV Medicine|July 16, 2010
Detecting impaired glucose tolerance or type 2 diabetes mellitus by means of an oral glucose tolerance test in HIV-infected patientsN Gianotti, F Visco, L Galli, et al.
Archives of Gerontology and Geriatrics|January 1, 1996
Aspects of sleep in centenariansF L Spadafora, A Curti, R Teti, et al.
HIV Medicine|February 19, 2016
Infection-related and -unrelated malignancies, HIV and the aging populationL Shepherd, Áh Borges, B Ledergerber, et al.
HIV Medicine|September 22, 2012
Number of daily pills, dosing schedule, self-reported adherence and health status in 2010: a large cross-sectional study of HIV-infected patients on antiretroviral therapyN Gianotti, L Galli, B Bocchiola, et al.
Journal of Clinical & Laboratory Immunology|January 1, 1992
Cerebrospinal fluid beta 2-microglobulin in AIDS related central nervous system involvementA Lazzarin, A Castagna, G Cavalli, et al.
Jac-Antimicrobial Resistance|April 10, 2026
Antibacterial prophylaxis and antimicrobial stewardship in the era of innovative therapies for haematological malignancies: transplantation, cellular therapies and new drugsR Dell'Acqua, M H Parrinello, D Clerici, et al.
The Journal of Antimicrobial Chemotherapy|June 17, 2020
Analysis of the faecal microbiome during analytical treatment interruption in people with chronic HIV infection and long-lasting virological suppression (APACHE study)S Nozza, R Ferrarese, A Poli, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|September 22, 2010
Evolution patterns of raltegravir-resistant mutations after integrase inhibitor interruptionF Canducci, B Barda, E Ceresola, et al.
Pageof 15

Showing results (111-120 of 146) with videos related to

Sort By:
Pageof 15
HIV Medicine|August 19, 2011
The rate of accumulation of nonnucleoside reverse transcriptase inhibitor (NNRTI) resistance in patients kept on a virologically failing regimen containing an NNRTI*A Cozzi-Lepri, Paredes, A N Phillips, et al.
Journal of Neurology|January 1, 1997
A comparison of brain biopsy and CSF-PCR in the diagnosis of CNS lesions in AIDS patientsA d'Arminio Monforte, P Cinque, L Vago, et al.
HIV Medicine|July 16, 2010
Detecting impaired glucose tolerance or type 2 diabetes mellitus by means of an oral glucose tolerance test in HIV-infected patientsN Gianotti, F Visco, L Galli, et al.
Archives of Gerontology and Geriatrics|January 1, 1996
Aspects of sleep in centenariansF L Spadafora, A Curti, R Teti, et al.
HIV Medicine|February 19, 2016
Infection-related and -unrelated malignancies, HIV and the aging populationL Shepherd, Áh Borges, B Ledergerber, et al.
HIV Medicine|September 22, 2012
Number of daily pills, dosing schedule, self-reported adherence and health status in 2010: a large cross-sectional study of HIV-infected patients on antiretroviral therapyN Gianotti, L Galli, B Bocchiola, et al.
Journal of Clinical & Laboratory Immunology|January 1, 1992
Cerebrospinal fluid beta 2-microglobulin in AIDS related central nervous system involvementA Lazzarin, A Castagna, G Cavalli, et al.
Jac-Antimicrobial Resistance|April 10, 2026
Antibacterial prophylaxis and antimicrobial stewardship in the era of innovative therapies for haematological malignancies: transplantation, cellular therapies and new drugsR Dell'Acqua, M H Parrinello, D Clerici, et al.
The Journal of Antimicrobial Chemotherapy|June 17, 2020
Analysis of the faecal microbiome during analytical treatment interruption in people with chronic HIV infection and long-lasting virological suppression (APACHE study)S Nozza, R Ferrarese, A Poli, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|September 22, 2010
Evolution patterns of raltegravir-resistant mutations after integrase inhibitor interruptionF Canducci, B Barda, E Ceresola, et al.
Pageof 15